You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone Substitutes, and Hormone Antagonists

Showing 1 - 25 of 6,185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infertility, Female, Infertility, Genital Diseases, Male Trial in Jette (Dydrogesterone Oral Tablet, Micronized progesterone,

Completed
  • Infertility, Female
  • +9 more
  • Dydrogesterone Oral Tablet
  • +3 more
  • Jette, Brussel, Belgium
    Centrum voor Reproductieve Geneeskunde
Dec 14, 2020

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 22, 2022

Transgenderism, Clotting Disorder Trial in Milwaukee (Estradiol Tablets, Transdermal patch)

Terminated
  • Transgenderism
  • Clotting Disorder
  • Estradiol Tablets
  • Transdermal patch
  • Milwaukee, Wisconsin
    Froedtert Hospital
Dec 19, 2022

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)

Recruiting
  • Prostatic Neoplasms
  • +16 more
  • Birmingham, Alabama
  • +296 more
Jan 18, 2023

Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)

Completed
  • Transgender Women
  • Estradiol
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    Faculty of Sports Science, Chulalongkorn University
Nov 2, 2023

Advanced Breast Cancer Trial in Worldwide (Ribociclib, fulvestrant, Ribociclib )

Active, not recruiting
Has Results
  • Advanced Breast Cancer
  • Mobile, Alabama
  • +173 more
Aug 4, 2022

Ovulation Induction Trial (corifollitropin alfa, recombinant Follicle Stimulating Hormone (recFSH), human Chorion Gonadotropin

Terminated
Has Results
  • Ovulation Induction
  • corifollitropin alfa
  • +3 more
  • (no location specified)
Feb 1, 2022

Diabetic Macular Edema Trial (OXU-001, Semi-automated suprachoroidal illuminated microcatheter, Ozurdex® Ophthalmic Intravitreal

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 24, 2023

ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, Anastrozole, Anastrozole )

Recruiting
  • ER-Positive HER2-Negative Breast Cancer
  • Mobile, Alabama
  • +285 more
Jan 28, 2022

Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,

Terminated
  • Spinal Cord Injury
  • +10 more
  • Testosterone Enanthate
  • +3 more
  • Tampa, Florida
  • +1 more
Jul 28, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (FT-7051)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Scottsdale, Arizona
  • +7 more
May 12, 2022

Infertility Trial (Org 36286, Placebo)

Completed
  • Infertility
  • Org 36286
  • Placebo
  • (no location specified)
Feb 1, 2022

Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis Trial in Tampa (5 mg prednisone, 0 mg prednisone)

Active, not recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • 5 mg prednisone
  • 0 mg prednisone
  • Tampa, Florida
    University of South Florida TAPIR Study Team
May 2, 2022

Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)

Recruiting
  • Heart Failure
  • Thyroid hormone T3
  • Control Group
  • Atlanta, Georgia
  • +1 more
Nov 14, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasms
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Macquarie University, New South Wales, Australia
  • +131 more
Jan 5, 2023

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Infertility, In Vitro Fertilization Trial (Org 36286, Puregon®, Orgalutran®)

Completed
  • Infertility
  • In Vitro Fertilization
  • Org 36286
  • +3 more
  • (no location specified)
Feb 1, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Study of Adrenal Gland Tumors

Completed
  • Adrenal Gland Neoplasm
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Boston, Massachusetts
    • +7 more
    Aug 14, 2023

    Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,

    Recruiting
    • Endometrial Neoplasm Malignant Stage I
    • Megestrol Acetate 160 MG Oral Tablet
    • +3 more
    • Shanghai, Shanghai, China, China
      Obstetrics and Gynecology Hospital, Fudan University
    Mar 25, 2022

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

    Recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • 6-month course of antiandrogen drugs
    • Long-term course of antiandrogen drugs
    • Nanjing, Jiangsu, China
      Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
    Jul 13, 2023

    Preterm Birth, Premature Birth, Complication of Prematurity Trial in Australia, Canada (Celestone + , Celestone + Celestone)

    Not yet recruiting
    • Preterm Birth
    • +4 more
    • Celestone + placebo
    • Celestone + Celestone
    • Newcastle, New South Wales, Australia
    • +40 more
    Sep 14, 2022